The Mythical Taboo on Race and Intelligence
By John P. Jackson, Jr., Andrew S. Winston,
Review of General Psychology
| 10. 07. 2020
Recent discussions have revived old claims that hereditarian research on race differences in intelligence has been subject to a long and effective taboo. We argue that given the extensive publications, citations, and discussions of such work since 1969, claims of taboo and suppression are a myth. We critically examine claims that (self-described) hereditarians currently and exclusively experience major misrepresentation in the media, regular physical threats, denouncements, and academic job loss. We document substantial exaggeration and distortion in such claims. The repeated assertions that the negative reception of research asserting average Black inferiority is due to total ideological control over the academy by “environmentalists,” leftists, Marxists, or “thugs” are unwarranted character assassinations on those engaged in legitimate and valuable scholarly criticism.
For several decades, hereditarian researchers who focused on race1 have claimed that they face special hurdles in conducting, publishing, and publicizing their research. Many claim that “work supporting hereditarianism can be much more difficult to publish and disseminate, and research testing the possible genetic basis of race differences is rarely funded” (Cofnas, 2020, p. 132; see also...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...